30 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know http://www.zacks.com/stock/news/426494/teva-pharmaceutical-industries-ltd-teva-stock-sinks-as-market-gains-what-you-should-know?cid=CS-ZC-FT-426494 Jun 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.26 in the latest trading session, marking a -1.59% move from the prior day.
Teva hits 19-year low on continued pricing pressure https://seekingalpha.com/news/3470793-teva-hits-19-year-low-continued-pricing-pressure?source=feed_news_all Jun 12, 2019 - Teva Pharmaceutical Industries (TEVA -4.2%) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the cont
Stocks making the biggest moves midday: Mattel, CrowdStrike, Dave & Buster's https://www.cnbc.com/2019/06/12/stocks-making-the-biggest-moves-midday-mattel-crowdstrike-dave-busters.html Jun 12, 2019 - Names on the move ahead of the open.
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status http://www.zacks.com/stock/news/431105/jazzs-jazz-new-sleep-drug-sunosi-gets-schedule-iv-status?cid=CS-ZC-FT-431105 Jun 18, 2019 - Jazz Pharmaceuticals' (JAZZ) recently approved sleep drug, Sunosi, receives schedule IV designation under controlled substance list from the Drug Enforcement Agency.
Mylan And Teva: History Shows Buying The Current Pain Could Be Your Big Future Gain https://seekingalpha.com/article/4271328-mylan-teva-history-shows-buying-current-pain-big-future-gain?source=feed_sector_healthcare Jun 20, 2019 - Buying stocks that have declined to bargain levels due to negative headlines and sentiment can pay off big.Mylan and Teva shares are extremely oversold and now trade for just about 4 times earnings.Bo
Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries https://www.fool.com/investing/2019/05/22/better-turnaround-play-bausch-health-companies-or.aspx?source=iedfolrf0000001 May 22, 2019 - Which of these fallen stars has the more compelling comeback story?
Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo ... http://www.gurufocus.com/news/883458/orbimed-advisors-llc-buys-neurocrine-biosciences-inc-teva-pharmaceutical-industries-endo-international-plc-sells-biogen-inc-celgene-corp-allergan-plc May 22, 2019 - Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo International PLC, Sells Biogen Inc, Celgene Corp, Allergan PLC, Stocks: NBIX,EW,MGTX,BMY,MYOK,APLS,TEVA,ENDP,PRTA,CDNA,CBA, release date:May 22, 2019
Teva settles with Oklahoma for $85 million in opioid case http://www.startribune.com/teva-settles-with-oklahoma-for-85-million-in-opioid-case/510449062/ May 26, 2019 - One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.
Oklahoma opioid claims cost Teva $85M https://seekingalpha.com/news/3466934-oklahoma-opioid-claims-cost-teva-85m?source=feed_news_all May 26, 2019 - Teva Pharmaceutical (NYSE:TEVA) has agreed to an $85M settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the
Teva settles opioid case with Oklahoma for $85M https://seekingalpha.com/news/3467024-teva-settles-opioid-case-oklahoma-85m?source=feed_news_all May 28, 2019 - Without admitting any wrongdoing, Teva Pharmaceutical Industries (NYSE:TEVA) has agreed to settle claims by the U.S. state of Oklahoma over its role in the opioid crisis there via a one-time payment o

Pages: 123

<Page 2